Physician profile
Michael Gould
NPI 1528591781
$7,458.05
in general payments reported to CMS, 2019-2025
10 companies · $5,071 in 2025
The $5,071 reported for 2025 was more than what 85% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $679 · 2024: $1,708 · 2025: $5,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,883 · Travel and Lodging: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,883.10 |
| Travel and Lodging | $1,574.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,591.33 | 2023-2025 | Indigo System, Penumbra System, Ruby Coil |
| Inari Medical, INC. | $1,321.50 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $763.54 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Optablate |
| Medtronic, INC. | $219.10 | 2024-2025 | Concerto Versa, Concertotm, Abre |
| Heartflow, INC. | $193.38 | 2025 | |
| Sirtex Medical INC | $191.63 | 2024-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Boston Scientific Corporation | $116.32 | 2024-2025 | Embold Fibered, Icefx Cryoablation System, Cryoablation Needles |
| Philips North America LLC | $28.18 | 2024 | (Br5) Peripheral Ivus |
| Mozarc Medical US LLC | $19.30 | 2025 | Palindrome |
| Bard Peripheral Vascular, INC. | $13.77 | 2025 | Denali Vena Cava Filter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.